Michael Ackermann, PhD
Michael is currently Vice President, Neurostimulation for Allergan, plc, and most recently CEO of Oculeve, Inc., which was acquired by Allergan. He has twelve years of experience in medical technology development in both academic and industrial settings in the fields of ophthalmology, chronic pain and movement disorders. He received a BE degree, magna cum laude, in biomedical engineering from Vanderbilt University, MS and PhD degrees in biomedical engineering from Case Western Reserve University, is a graduate of the Stanford University Biodesign fellowship, and Vision Research Fellow at Stanford. He has numerous patents and peer-reviewed publications.